Kyntra Bio Appointed New Board Member
The San Francisco biotech firm replaced a veteran director with a financial consultant.
Updated on Oct. 1, 2026 in People
Kyntra Bio has appointed Andrew E. Singer to its Board of Directors and Audit Committee. The move follows the departure of long-serving board member Maykin Ho.
Why it matters
Board transitions often signal shifts in governance focus, particularly when replacing an eight-year veteran with an executive who brings significant experience in capital markets and financial advisory.
The transition replaces eight years of board tenure with an appointee holding 25 years of professional experience and a track record of advising on $50 billion in transactions.
The players
Kyntra Bio
A San Francisco-based biotechnology company focused on research and development.
Andrew E. Singer
The current CEO of Fika Bio Consulting with 25 years of experience in capital markets.
Maykin Ho
A former director who served on the Kyntra Bio board for eight years.
The details
Andrew E. Singer joins the board and Audit Committee after serving as the CEO of Fika Bio Consulting. His professional background includes previous tenures at Credit Suisse, Wells Fargo, and RBC Capital Markets. These financial services roles typically provide oversight expertise relevant to high-growth sectors like biotechnology.
Timeline
Maykin Ho stepped down from the Board of Directors on September 30, 2026.
Andrew E. Singer joined the Board of Directors on October 1, 2026.
Market Landscape
This transition aligns with the industry trend of biotech firms prioritizing deep capital markets expertise within board governance. It marks a shift from long-term institutional tenure toward specialized advisory backgrounds as the company manages its financial oversight.
Operators should monitor whether the shift toward a financial-advisory focus on the Audit Committee signals a change in the company's capital allocation strategy. Review current board oversight structures to ensure they remain aligned with your own business lifecycle stage.
The takeaway
Board oversight remains a critical lever for aligning corporate governance with current market realities. Operators should audit their own advisory boards periodically to determine if current skill sets match future growth needs.
Further reading
For more updates on corporate leadership, visit People.
